Diagnosis and treatment of patients with severe Alzheimer's disease.

Abstract:

:In contrast with the earlier stages and, in particular, the predementia stage, of Alzheimer's disease (AD), severe dementia is often neglected. However, the advanced stages of dementia are just as important as the earlier stages because of their frequency, their impact on the lives of patients and their caregivers, and their economic consequences. All patients with moderately severe to severe dementia must be evaluated for cognitive, functional, psychological and behavioural symptoms. Thorough and regular evaluation of patients in the advanced stages of the disease has the following objectives: improving patients' quality of life by encouraging use of their remaining capacities; setting up or modifying a care plan; playing a role in the follow-up of measures instituted; and documenting the natural history of the disease. Therapeutic trials with cholinesterase inhibitors and memantine have been conducted in patients with severe stages of AD. As a consequence, memantine has been approved by numerous drug agencies and donepezil has been approved by the US FDA for use in severe stages of the disease. However, it is important to note that at this stage of AD, and perhaps more than in any other, management must be global and multidisciplinary because of the expression of the disease, its complications and intercurrent disorders. Indeed, thorough knowledge by health professionals of the expression of all disease disorders and intercurrent disorders, and of their significance during the severe stage of AD, is important in the management of these patients to limit complications and facilitate prompt establishment of appropriate care. More effort is needed in both clinical and research settings to ensure that patients with severe AD and their relatives can be offered optimal management.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Voisin T,Vellas B

doi

10.2165/0002512-200926020-00005

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

135-44

issue

2

eissn

1170-229X

issn

1179-1969

pii

2625

journal_volume

26

pub_type

杂志文章,评审
  • Optimal management of gout in older patients.

    abstract::Gout in older patients tends to be sub-acute to chronic, often tophaceous, polyarticular, erosive, symmetrical, and causes persistent, recurrent and chronic arthritis. Clinically, it may closely mimic rheumatoid arthritis; thus, a correct diagnosis requires a high index of clinical suspicion and the identification of ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199404020-00005

    authors: Gonzalez EB,Miller SB,Agudelo CA

    更新日期:1994-02-01 00:00:00

  • Clinical, demographic and functional characteristics associated with pharmacotherapy for heart failure in older home care clients: a retrospective, population-level, cross-sectional study.

    abstract:BACKGROUND:Use of combination pharmacotherapy, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) and β-adrenoceptor antagonists (β-blockers) in the management of heart failure (HF) can reduce mortality, prevent functional decline and red...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11592420-000000000-00000

    authors: Foebel AD,Heckman GA,Hirdes JP,Tyas SL,Tjam EY,McKelvie RS,Maxwell CJ

    更新日期:2011-07-01 00:00:00

  • Inappropriate prevention of NSAID-induced gastrointestinal events among long-term users in the elderly.

    abstract::Although use of NSAIDs and aspirin (acetylsalicylic acid) is well known to be associated with gastrointestinal (GI) complications and potential mortality, these medications continue to be widely prescribed in the elderly. Age is a significant risk factor for NSAID-induced GI events; indeed, patients >75 years of age c...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200724020-00004

    authors: Lanas A,Ferrandez A

    更新日期:2007-01-01 00:00:00

  • Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

    abstract::Amitriptyline is a tricyclic antidepressant agent which also has analgesic properties. Whether its analgesic effects are linked to its mood-altering activity or attributable to a discrete pharmacological action (or a combination of both) is unknown. Clinical trials demonstrate that oral amitriptyline achieves at least...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199608060-00008

    authors: Bryson HM,Wilde MI

    更新日期:1996-06-01 00:00:00

  • Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.

    abstract:OBJECTIVE:To review the influence of age on the response of patients with idiopathic thrombocytopenic purpura (ITP) to corticosteroids, splenectomy and danazol. METHODS:We retrospectively reviewed a cohort of 139 consecutively treated patients with ITP diagnosed between 1985 and 1994. In particular, we analysed the th...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320110-00005

    authors: Andrès E,Zimmer J,Noel E,Kaltenbach G,Koumarianou A,Maloisel F

    更新日期:2003-01-01 00:00:00

  • Mechanisms of age-related endocrine alterations. Part II.

    abstract::Aging is associated with a myriad of hormonal changes. The mechanisms underlying these changes are variable. Aging is associated with anatomic changes of the endocrine glands, notably as a result of programmed cell death, autoimmune mediated destruction of the gland, or neoplastic transformation of glandular tissue. A...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199303020-00004

    authors: Mooradian AD

    更新日期:1993-03-01 00:00:00

  • Factors influencing the implementation of quality use of medicines in residential aged care.

    abstract:BACKGROUND:In response to concerns about, and issues pertaining to, medication use practices in residential aged-care facilities (RACFs), the Australian Pharmaceutical Advisory Council (APAC) established a working party on quality use of medicines (QUM) in nursing homes and hostels. The APAC is a representative ministe...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421120-00005

    authors: Cheek J,Gilbert A,Ballantyne A,Penhall R

    更新日期:2004-01-01 00:00:00

  • Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.

    abstract:BACKGROUND:Inappropriate medications are often used in older adults despite their unfavourable risk-to-benefit profile. Although many of the medications in the American Geriatrics Society (AGS) Beers list are potentially inappropriate because of their anticholinergic properties, little is known regarding the nature and...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-015-0257-x

    authors: Kachru N,Carnahan RM,Johnson ML,Aparasu RR

    更新日期:2015-05-01 00:00:00

  • Population Pharmacokinetic/Pharmacodynamic Modeling of O-Desmethyltramadol in Young and Elderly Healthy Volunteers.

    abstract:BACKGROUND:Age-related changes in the concentration-effect relationship of (+)-O-desmethyl-tramadol [(+)-ODM], tramadol's active metabolite, are not documented in the elderly. OBJECTIVE:The objective of this study was to characterize, in elderly and young subjects, the (+)-ODM pharmacokinetic and pharmacodynamic relat...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40266-019-00681-w

    authors: Robertson SS,Mouksassi MS,Varin F

    更新日期:2019-08-01 00:00:00

  • Outpatient medications and hip fractures in the US: a national veterans study.

    abstract:BACKGROUND:Certain medications have been linked to falls. One of the most severe fall-related injuries in the elderly is a hip fracture. OBJECTIVE:The objective of this study was to examine the use of medications known to increase fall risk that were prescribed on an outpatient basis to veterans prior to hospital admi...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200522100-00006

    authors: French DD,Campbell R,Spehar A,Cunningham F,Foulis P

    更新日期:2005-01-01 00:00:00

  • Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

    abstract:OBJECTIVE:Adverse drug reactions (ADRs) represent a major public health problem in the aged. In order to better evaluate this problem in Brazil, this study was designed to assess the prevalence of ADRs in an elderly hospitalised population, identify the most common ADRs and the principal medications involved, evaluate ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200522090-00005

    authors: Passarelli MC,Jacob-Filho W,Figueras A

    更新日期:2005-01-01 00:00:00

  • Evidence-Based Management of Diabetes in Older Adults.

    abstract::The number of older adults with diabetes is rapidly increasing worldwide. A variety of factors contribute to the age-related increase in the incidence of diabetes. The lack of empiric evidence in the field has limited the management guidelines to mostly expert opinion. Given uncertainty over the rate at which to lower...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-018-0598-3

    authors: Mooradian AD

    更新日期:2018-12-01 00:00:00

  • Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin.

    abstract::Overactive bladder (OAB) is a common constellation of lower urinary tract storage symptoms that causes a significant impact on a person's quality of life. The elderly may be disproportionally impacted by these symptoms due to concomitant poor mobility, comorbid conditions such as diabetes and heart failure, and polyph...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-015-0301-x

    authors: McFerren SC,Gomelsky A

    更新日期:2015-10-01 00:00:00

  • Sedative load and mortality among residents of long-term care facilities: a prospective cohort study.

    abstract:BACKGROUND:Older people are often prescribed multiple drugs with sedative properties. Most research has focused on specific classes of sedative and psychotropic drugs. The cumulative effect of taking multiple drugs with sedative properties has been termed 'sedative load'. Few previous studies have investigated the seda...

    journal_title:Drugs & aging

    pub_type: 临床试验,杂志文章

    doi:10.2165/11317080-000000000-00000

    authors: Taipale HT,Bell JS,Soini H,Pitkälä KH

    更新日期:2009-01-01 00:00:00

  • Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.

    abstract:BACKGROUND:In the presence of multimorbidity and limited life expectancy (LLE), the need for continued use of preventive medicines becomes uncertain as they may neither improve health nor confer continued health benefits. OBJECTIVE:Our objective was to systematically review the literature to examine the discontinuatio...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0487-1

    authors: Narayan SW,Nishtala PS

    更新日期:2017-10-01 00:00:00

  • Economic evaluation of ropinirole prolonged release for treatment of Parkinson's disease in the Netherlands.

    abstract:BACKGROUND:By using the findings obtained from the PREPARED study, we aimed to estimate the cost effectiveness of ropinirole prolonged release (PR) [Requip-Modutab(®)] in Parkinson's disease (PD) versus ropinirole immediate release (IR). In the PREPARED study, ropinirole PR provided a significantly greater improvement ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-013-0150-4

    authors: van Boven JF,Novak A,Driessen MT,Boersma C,Boomsma MM,Postma MJ

    更新日期:2014-03-01 00:00:00

  • Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

    abstract:PURPOSE:To determine the association between changes in complete blood counts and grade 3 or 4 toxicities from cycle 1 to cycle 2 during adjuvant chemotherapy in women > or =65 years of age with breast cancer. DESIGN AND METHODS:A retrospective review was performed on 1405 patients > or =65 years of age who were treat...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200522080-00007

    authors: Hurria A,Brogan K,Panageas KS,Jakubowski A,Zauderer M,Pearce C,Norton L,Howard J,Hudis C

    更新日期:2005-01-01 00:00:00

  • Molecular rationale for the pharmacological treatment of Alzheimer's disease.

    abstract::Cerebral deposition of amyloid plaques containing amyloid beta-peptide (Abeta) has traditionally been considered the central feature of Alzheimer's disease (AD). Abeta is derived from amyloid precursor protein (APP), which is cleaved by several different proteases: alpha-, beta- and gamma-secretase. In the past decade...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522001-00003

    authors: Zimmermann M,Gardoni F,Di Luca M

    更新日期:2005-01-01 00:00:00

  • Rational approach to the antibiotic treatment of pneumonia in the elderly.

    abstract::The incidence of pneumonia is highest among the aged compared with other adult populations, and causes significant morbidity and mortality among this group. Most episodes of pneumonia are caused by aspiration of oropharyngeal flora into the lungs and failure of lung defence mechanisms to eliminate the aspirated bacter...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199404010-00003

    authors: Mylotte JM,Ksiazek S,Bentley DW

    更新日期:1994-01-01 00:00:00

  • Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS2 Score ≥ 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants?

    abstract:OBJECTIVE:Our objectives were to (1) describe the evolution of the underuse of anticoagulants in older people with atrial fibrillation (AF) and a CHADS2 score ≥ 2 since direct oral anticoagulants (DOACs) were introduced to the market and (2) describe factors associated with this underuse. METHODS:We conducted a retros...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-017-0493-3

    authors: Henrard S,Vandenabeele C,Marien S,Boland B,Dalleur O

    更新日期:2017-11-01 00:00:00

  • Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.

    abstract::An increasing number of elderly patients are exposed to cardiovascular drugs for the treatment of acute and/or chronic conditions. This is a result of the progressive aging of the population, a common feature in most industrialised countries, and an improvement in primary and secondary cardiovascular prevention strate...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522110-00003

    authors: Mangoni AA

    更新日期:2005-01-01 00:00:00

  • Decitabine: a review of its use in older patients with acute myeloid leukaemia.

    abstract::Decitabine (Dacogen(®)) is a deoxynucleoside analogue of cytidine that selectively inhibits DNA methyltransferases. Decitabine administered at a dose of 20 mg/m(2) by a 1-h intravenous infusion for 5 consecutive days of a 4-week cycle has been approved by the European Medicines Agency (EMA) for use in adult patients a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-013-0084-x

    authors: Curran MP

    更新日期:2013-06-01 00:00:00

  • Disparities in combination drug therapy use in older adults with coronary heart disease: a cross-sectional time-series in a nationally representative US sample.

    abstract:BACKGROUND:Despite evidence of effective combination drug therapy for secondary prevention of coronary heart disease (CHD), older adults with this condition remain undertreated. OBJECTIVE:To describe time trends (1992-2003) in the adoption of combination cardiac drug therapies (beta-blockers [beta-adrenoceptor antagon...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11532150-000000000-00000

    authors: Tjia J,Briesacher B,Xie D,Fu J,Goldberg RJ

    更新日期:2010-02-01 00:00:00

  • Pharmacological approaches to the prevention of restenosis after coronary angioplasty.

    abstract::Restenosis in the months following a successful percutaneous transluminal coronary angioplasty (PTCA) remains the main limitation to this technique for myocardial revascularisation. Despite intensive investigation in this area, no pharmacological therapy has yet been found to be useful in preventing restenosis after c...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199813040-00005

    authors: Hamon M,Lécluse E,Monassier JP,Grollier G,Potier JC

    更新日期:1998-10-01 00:00:00

  • Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.

    abstract::The 2013 American College of Cardiology (ACC) and American Heart Association (AHA) practice guidelines for the treatment of blood cholesterol significantly changed the paradigm of how providers should prescribe statin therapy, especially for older adults. While the evidence supports statin therapy for older adults wit...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0238-5

    authors: Weinberger Y,Han BH

    更新日期:2015-02-01 00:00:00

  • The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.

    abstract::The median age for breast cancer diagnosis is 62 years, but a disproportionate number of patients are over the age of 75 years and the majority of those have hormone receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative cancers. This review provides a logical algorithm to guide providers through ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-020-00748-z

    authors: Sammons S,Sedrak MS,Kimmick GG

    更新日期:2020-05-01 00:00:00

  • Vitreous haemorrhage in elderly patients: management and prevention.

    abstract::Vitreous haemorrhage can be caused by a disruption of normal retinal vessels, bleeding from diseased retinal vessels, bleeding from abnormal new vessels or extension of haemorrhage through the retina from other sources. In the elderly, vitreous haemorrhage usually occurs spontaneously and only occurs occasionally as a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320090-00003

    authors: Manuchehri K,Kirkby G

    更新日期:2003-01-01 00:00:00

  • Rosuvastatin in elderly patients.

    abstract::A progressive accumulation of atherosclerotic lesions beginning early in life puts elderly persons at a greater absolute risk of cardiovascular disease and coronary events than other segments of the population. HMG-CoA reductase inhibitor (statin) therapy has been shown to be both efficacious and well tolerated in mos...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200724110-00005

    authors: Davidson MH

    更新日期:2007-01-01 00:00:00

  • Spasticity after stroke. Epidemiology and optimal treatment.

    abstract::Spasticity following stroke reflects a spectrum of clinical problems including increased muscle tone, abnormal limb posture, excessive contraction of antagonist muscles and hyperactive cutaneous and tendon reflexes. The prevalence of stroke-related disability in stroke survivors is high, and spasticity may be a signif...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199609050-00004

    authors: O'Brien CF,Seeberger LC,Smith DB

    更新日期:1996-11-01 00:00:00

  • The Role of Deprescribing in Older Adults with Chronic Kidney Disease.

    abstract::Older adults with chronic kidney disease (CKD) often experience polypharmacy, a recognized predictor of prescribing problems including inappropriately dosed medications, drug-drug and drug-disease interactions, morbidity and mortality. Polypharmacy is also associated with nonadherence, which leads to recurrent hospita...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-018-0593-8

    authors: Triantafylidis LK,Hawley CE,Perry LP,Paik JM

    更新日期:2018-11-01 00:00:00